Health Care Stocks
← Back to SectorsCompare ranked Health Care stocks and quickly see their AI Score, Momentum, and Price Score.
Together, these signals give you a simple view of longer-term potential, recent market strength, and short-term price conditions.
Companies providing medical services, equipment, or manufacturing pharmaceuticals and biotechnology.
How to read the scores
Three complementary signals, each answering a different investor question.
AI ScoreModel conviction informed by quality, value, risk and stability.
Price + MomentumIndependent market signals for price setup and trend strength.
Use as researchCompare signals together; they are not guarantees or investment advice.
Data shown reflects the U.S. market close on 2026-11-11.
Ranked sector stocks
| # | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | Aktis Oncology, Inc. | Health Care | XNAS | $1.3B | - | 4.88 Strong | 45.9 | 2.2 | |
| 2 | Apnimed Inc. | Health Care | XNAS | $1.2B | - | 4.88 Strong | 46.3 | 2.1 | |
| 3 | Bicara Therapeutics Inc. | Health Care | XNAS | $1.6B | - | 4.88 Strong | 44.9 | 2.2 | |
| 4 | WW International, Inc. | Health Care | XNAS | $2.7B | 3.56 | 4.88 Strong | 50.4 | 2.3 | |
| 5 | Avalo Therapeutics, Inc. | Health Care | XNAS | $1.0B | - | 4.76 Strong | 41.9 | 2.3 | |
| 6 | Axsome Therapeutics, Inc | Health Care | XNAS | $10.9B | - | 4.76 Strong | 47.1 | 2.2 | |
| 7 | Obsidian Therapeutics, Inc. | Health Care | XNAS | $1.1B | - | 4.76 Strong | 50.2 | 2.2 | |
| 8 | COMPASS Pathways plc | Health Care | XNAS | $1.8B | - | 4.72 Strong | 46.4 | 2.3 | |
| 9 | uniQure N.V. | Health Care | XNAS | $3.1B | - | 4.68 Strong | 44.6 | 2.4 | |
| 10 | Intercure Ltd. | Health Care | XNAS | $6.4B | 5.00 | 4.64 Strong | 49.3 | 2.1 | |
| 11 | Alumis Inc. | Health Care | XNAS | $1.4B | - | 4.56 Strong | 41.5 | 2.3 | |
| 12 | Stevanato Group S.p.A. | Health Care | XNYS | $5.6B | 35.65 | 4.56 Strong | 48.2 | 2.0 | |
| 13 | Freenome, Inc. | Health Care | XNAS | $1.5B | - | 4.48 Positive | 51.9 | 2.1 | |
| 14 | Madrigal Pharmaceuticals, Inc. | Health Care | XNAS | $12.7B | - | 4.48 Positive | 50.3 | 2.3 | |
| 15 | Kura Oncology, Inc. | Health Care | XNAS | $1.2B | - | 4.44 Positive | 48.7 | 2.2 | |
| 16 | Oculis Holding AG | Health Care | XNAS | $5.0B | 17.28 | 4.44 Positive | 46.8 | 2.2 | |
| 17 | Alvotech | Health Care | XNAS | $1.9B | 51.90 | 4.36 Positive | 49.9 | 2.2 | |
| 18 | Butterfly Network, Inc. | Health Care | XNYS | $2.0B | - | 4.36 Positive | 48.3 | 2.4 | |
| 19 | Nurix Therapeutics, Inc. | Health Care | XNAS | $2.8B | - | 4.36 Positive | 49.7 | 2.2 | |
| 20 | Definium Therapeutics, Inc. | Health Care | XNAS | $5.2B | - | 4.32 Positive | 52.5 | 2.2 | |
| 21 | Harrow, Inc. | Health Care | XNAS | $1.4B | 164.57 | 4.28 Positive | 46.5 | 2.2 | |
| 22 | ArriVent BioPharma, Inc. | Health Care | XNAS | $1.4B | - | 4.24 Positive | 45.5 | 2.2 | |
| 23 | Regencell Bioscience Holdings Limited | Health Care | XNAS | $3.2B | - | 4.24 Positive | 51.2 | 2.2 | |
| 24 | Attovia Therapeutics Inc. | Health Care | XNAS | $1.2B | - | 4.20 Positive | 44.9 | 2.2 | |
| 25 | CVS HEALTH CORPORATION | Health Care | XNYS | $122.0B | 25.40 | 4.16 Positive | 49.8 | 2.5 |
Price Score: momentum composite, 1–5. Methodology

